Connect with us

Agricultural Inputs

India Pesticides Limited Q2 and H1 FY27 Earnings: Revenue Decline Amid Cost Management

India Pesticides Limited (IPL) reports Q2 FY27 earnings with a revenue decline, EBITDA margin at 14.4%, and strategic international expansions.

jyoti sharma

Published

on

India Pesticides Limited IPL Q2 FY27 Earnings

India Pesticides Limited (IPL) has announced its financial results for the quarter and half year ended 30th September 2026. Despite challenges, the company reported a revenue from operations of Rs. 231 crore in Q2 FY27, down 21.6% compared to Rs. 295 crore in Q2 FY26. The EBITDA for Q2 FY27 was Rs. 33 crore, with an EBITDA margin of 14.4%, compared with Rs. 54 crore and 18.2% respectively in Q2 FY26. The decline was primarily due to softer demand for herbicides in the overseas market, regional instability, and volatility in key material prices. Inland sales also decreased due to deficient and erratic rainfall across several parts of India.

H1 FY27 Performance

For the first half of FY27, revenue from operations was Rs. 487 crore, down 15.9% compared to Rs. 579 crore in H1 FY26. EBITDA was Rs. 73 crore, with an EBITDA margin of 14.9%, compared with Rs. 108 crore and 18.6% respectively in H1 FY26. Lower sales, combined with higher employee expenses and raw material price volatility, weighed on profitability. However, the company received Technical Equivalence approval for one of its insecticide products in the United Kingdom and registration for one of its herbicide products in Argentina, creating opportunities for new customers and broadening the export portfolio.

Strategic Direction

Commenting on the performance, Mr. Dheeraj Kumar Jain, Chief Executive Officer, said, ‘The second quarter of FY27 presented a challenging operating environment, with geopolitical uncertainty, softer overseas demand, and volatility in key raw material prices affecting business conditions. In India, deficient and erratic rainfall across several agricultural states disrupted cropping cycles and reduced herbicide application. As a result, our focus remained on managing costs, maintaining operational discipline, and progressing our international growth strategy.’ IPL continues to prioritize process optimization, backward integration, and the development of differentiated molecules and intermediates to improve manufacturing economics, reduce import dependence, and expand the product range offered to customers.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of India Pesticides Limited

India Pesticides Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

IPL
Basic Materials › Agricultural Inputs
APPROACHING SUPPORT
46
Fundamental
58
Technical
52
Overall

1W -1.52%
1M -7.82%
3M -16.27%
P/E: 13.6 Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

India drops 16.3% over three months and trades near its 52-week lows. Revenue contracts at 6.2% CAGR. That signals structural headwinds, not a short-term blip. The stock sits at 3% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 6.2% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of India Pesticides Limited.

ADVANCE

Advance Agrolife Limited (advance) Q2 & H1 FY27: PAT Up 38.4%, Revenue Hits ₹6175.6 Cr

Advance Agrolife Limited (NSE: ADVANCE) reports a 38.4% Y-o-Y increase in PAT and a 62% rise in revenue for H1 FY27.

Blogger Kapil Rohilla TradeAlone

Published

on

Advance Agrolife Limited (advance) Q2 & H1 FY27 Results

Advance Agrolife Limited (NSE: ADVANCE), a leading agri-input company, has announced its financial results for the second quarter and the half year ended on September 30, 2026. The company reported a Profit After Tax (PAT) of ₹343.4 million, marking a 38.4% year-on-year increase. Total revenue for the half year stood at ₹6175.6 million, up by 62% Y-o-Y.

Financial Highlights

The company’s EBITDA for H1 FY27 was ₹569.0 million, showing a 33% increase Y-o-Y. The EBITDA margin for the half year was 9.2%. In Q2 FY27, the EBITDA was ₹218.3 million.

Business Performance

Advance Agrolife Limited continued to strengthen its pan-India distribution network and deepened its B2B market presence, enhancing customer reach, market penetration, and institutional relationships. The company has expanded its export presence to 14 countries, including new markets like Libya, Myanmar, Oman, and Somalia. The extensive portfolio of over 500 CIB & RC product registrations remains a significant competitive advantage.

Forward-Looking

Mr Omprakash Choudhary, CMD of Advance Agrolife Limited, emphasized the company’s focus on building a resilient, scalable, and diversified business. The commissioning of the Gidhani Plant by the end of Q4 is expected to further strengthen the company’s manufacturing capabilities.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Advance Agrolife Limited

Advance Agrolife Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

ADVANCE
Basic Materials › Agricultural Inputs
BREAKOUT
78
Fundamental
92
Technical
85
Overall

1W +39.56%
1M +43.51%
3M +39.08%
P/E: 21.1 Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Advance gains 39.1% over three months and trades near its 52-week highs. The PEG of 0.63 signals undervaluation relative to growth. It is a potential re-rating candidate. Thin margins at 6.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. RSI hits 79, a level that signals the stock runs hot. Notably, buyers drove volume on 12 recent sessions — though at these levels, some profit-taking is normal. Both the business and the stock move in the right direction. Revenue grows at 17.1%, profits at 33.4%, and the PEG sits at 0.63 — below its growth rate. That combination is rare. Check Fundamentals of Advance Agrolife Limited.

Continue Reading

Agricultural Inputs

Meghmani Organics Limited Q2 FY27 Results: Revenue Up 18%, Net Profit Grows 6%

Meghmani Organics Limited (MOL) announced Q2 FY27 results with 18% revenue growth and 6% net profit increase.

Shruti singh - TradeAlone

Published

on

Meghmani Organics Limited Q2 FY27 Results

Meghmani Organics Limited (MOL) announced its financial results for the second quarter ended 30 September 2026 (Q2 FY27). The company reported a revenue of ₹658.2 crore, up by 18% year-on-year (YoY). Net profit increased by 6% YoY to ₹45.3 crore, while EBITDA remained flat YoY at ₹70.9 crore. EBITDA margin for the quarter was impacted by elevated input and logistics costs.

Segment Performance

Crop Protection constitutes ~75% of the overall company’s revenue in Q2 FY27. Revenue and EBITDA stood at ₹496.7 crore and ₹54.6 crore respectively. EBITDA margin stood at 11.0%. Capacity utilisation for the segment stood at 72%. Production stood at 10,019 MT, remaining flat YoY.

Half-Year Results

For the half year ended 30 September 2026 (H1 FY27), revenue from operations stood at ₹1,181.2 crore, up by 3% YoY. Net Profit increased by 23% YoY to ₹102.9 crore and EBITDA grew by 9% YoY to ₹164.6 crore. EBITDA margin stood at 13.9%. Commenting on Q2 FY27 performance, Mr. Ankit Patel, Chairman & Managing Director said “We delivered healthy 18% YoY growth in revenue during the quarter, reflecting a continued positive momentum. However, due to sharp increase in input and logistics costs, and realisations remaining broadly flat, our margins during the quarter were impacted. While the near-term cost environment remains challenging, we are taking focused measures to optimise our product mix and improve our operating efficiencies.”

About Meghmani Organics Limited: MOL is a fully integrated diversified chemical company with presence in the Crop Protection, Crop Nutrition and Pigments. MOL is amongst the top three global Phthalocyanine based pigment players enjoying an 8% market share and amongst the top-10 manufacturers of pesticides in India with a presence across the entire value chain. MOL has 40+ brands of various pesticides formulations in India and has over 400+ customer base across diverse industries. MOL has a global presence in 75+ countries and a wide distribution network of 3,500+ distributors and dealers across India. The company garners ~85% of its topline from the export markets as on FY26.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Meghmani Organics Limited

Meghmani Organics Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

MOL
Basic Materials › Agricultural Inputs
APPROACHING SUPPORT
32
Fundamental
70
Technical
51
Overall

1W +1.95%
1M +1.79%
3M +26.97%
P/E: 23.5 Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Meghmani rises 27.0% over three months, with buying pressure holding steady. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Revenue contracts at -5.3% CAGR. That signals structural headwinds, not a short-term blip. The stock holds at 49% of its 52-week range with RSI at 52. In other words, neither side has a clear edge right now. The stock rises 27.0% in three months. Yet revenue grows at only -5.3% and the PEG stands at 99.00. Either the market prices in a turnaround that has not shown up yet, or this is momentum without substance. Check the next two earnings prints before drawing conclusions. Check Fundamentals of Meghmani Organics Limited.

Continue Reading

Agricultural Inputs

Indogulf Cropsciences Limited (igcl) Q2 FY27: Ebitda Rises 27%, PAT Grows 24%

Indogulf Cropsciences Limited (NSE: IGCL) reports strong Q2 FY27 performance with EBITDA up 27% and PAT growing 24%.

Manas shah, Analyst — IT & Software

Published

on

Indogulf Cropsciences Limited IGCL Q2 FY27 Results

Indogulf Cropsciences Limited (NSE: IGCL | BSE: 544432) announced its consolidated unaudited financial results for the quarter and half year ended September 30, 2026, showcasing robust performance. The company’s EBITDA rose 27% year-on-year to ₹41 crore, while PAT increased by 24% to ₹26 crore. The EBITDA margin expanded by 300 basis points to 16%, reflecting disciplined cost management and a favorable product mix.

Financial Performance Snapshot

The company’s total income for Q2 FY27 stood at ₹256 crore, up 3% year-on-year. Despite weak monsoon conditions, the sequential revenue growth was 52% QoQ, indicating improved business momentum. The PAT margin improved to 10% from 8% due to lower finance costs and enhanced operating efficiencies.

Half-Year Performance

For H1 FY27, revenue from operations was ₹424 crore, showing a marginal decline of 3% YoY. However, gross profit increased by 7% to ₹123 crore, with the gross margin improving to 29%. EBITDA grew 20% to ₹50 crore, and the EBITDA margin expanded to 12%. The PAT increased 14% to ₹28 crore, with the PAT margin improving to 7%.

Looking Ahead

Commenting on the performance, Mr. Sanjay Aggarwal, Managing Director, Indogulf Cropsciences Limited, said: “We are pleased with our strong performance in Q2 FY27. The first half has seen similar progress, and we are entering the second half with strong business momentum. The national focus on raising farm productivity and farmer incomes, growing adoption of modern crop protection and crop nutrition, and the accelerating shift towards sustainable and biological solutions are creating strong tailwinds for integrated players like Indogulf.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Indogulf Cropsciences Limited

Indogulf Cropsciences Limited belongs to the › sector. Here’s a quick read on where the business and the stock stand today.

IGCL
Basic Materials › Agricultural Inputs
CONSOLIDATING DOWN
78
Fundamental
60
Technical
70
Overall

1W +10.8%
1M -6.48%
3M -13.69%
P/E: 11.8 Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Indogulf falls 13.7% over three months and has not found a floor yet. The PEG of 0.55 signals undervaluation relative to growth. It is a potential re-rating candidate. Thin margins at 5.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock sits at 19% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 8.6% and profits at 21.3% CAGR, with D/E of 0.00. Meanwhile, the stock dips 13.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Indogulf Cropsciences Limited.

Continue Reading

Trending

Exit mobile version